Octreotide Impurity 12 is a related peptide species formed during octreotide synthesis or degradation. Modifications in residue sequence or protecting-group history alter ring conformation and retention times. Researchers employ it as a reference to refine impurity limits and analytical sensitivity. Applications include QC method validation, stability testing, and structural-variant comparison.
CAT No: R2763
Synonyms/Alias:(R)-1-((2R,3R)-2-((4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamido)-3-hydroxybutoxy)-1-oxopropan-2-yl (R)-2-hydroxypropanoate; L-Lactolactoyl-Thr-Octreotide; Octreotide Impurity 12
Octreotide Impurity 12 is a synthetic peptide derivative related structurally to octreotide, a well-characterized somatostatin analog. As an impurity reference standard, it holds significant relevance in peptide chemistry and analytical quality control, allowing researchers and manufacturers to rigorously assess the identity, purity, and stability of octreotide-based products. The presence and quantification of such impurities are crucial for understanding degradation pathways, optimizing synthesis protocols, and ensuring the reliability of peptide-based research materials. Octreotide Impurity 12 is thus an essential tool for analytical laboratories, peptide manufacturers, and research institutions engaged in the development and quality assessment of complex peptide formulations.
Analytical method development: In the context of peptide pharmaceuticals, the accurate detection and quantification of related impurities are paramount for product characterization. Octreotide Impurity 12 serves as a critical reference standard in the development and validation of high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and mass spectrometry (MS) methods. By providing a well-defined benchmark, it enables analysts to establish robust separation parameters, optimize detection sensitivity, and ensure the specificity of analytical protocols targeting octreotide and its related substances.
Quality control and batch release: The use of structurally defined peptide impurities is integral to the quality assurance of synthetic peptide preparations. Laboratories engaged in the production or formulation of octreotide derivatives rely on well-characterized impurities such as this one to monitor batch-to-batch consistency and to detect any deviations in manufacturing processes. By incorporating Octreotide Impurity 12 into routine quality control assays, manufacturers can verify that impurity profiles remain within acceptable limits, thereby supporting the integrity and reproducibility of peptide research materials.
Stability studies and degradation profiling: Understanding the stability of peptide compounds under various storage and handling conditions is essential for both research and manufacturing. Octreotide Impurity 12 is frequently utilized in forced degradation studies to map potential breakdown products and to elucidate degradation pathways of octreotide. The availability of this impurity standard enables researchers to identify and quantify specific degradation products, facilitating comprehensive stability assessments and supporting the establishment of optimal storage guidelines for peptide products.
Peptide synthesis process optimization: Synthetic peptide production often involves complex reaction pathways that can give rise to a variety of side products and impurities. By employing Octreotide Impurity 12 as a process marker or reference, chemists can refine purification strategies and adjust synthetic protocols to minimize the formation of unwanted byproducts. Tracking the occurrence and levels of this impurity provides valuable feedback for process development teams, ultimately contributing to higher yields and improved product quality in peptide synthesis.
Regulatory submission support: For organizations preparing technical documentation for regulatory filings or research publications, the inclusion of well-characterized impurity standards is a critical requirement. The use of Octreotide Impurity 12 in analytical validation and impurity profiling ensures that documentation is comprehensive and scientifically robust. This practice enhances confidence in reported data, facilitates peer review, and supports compliance with best practices for peptide-based research and development activities.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More